These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 975718)

  • 41. Salicylate kinetics in old age.
    Netter P; Faure G; Regent MC; Procknal JA; Levy G
    Clin Pharmacol Ther; 1985 Jul; 38(1):6-11. PubMed ID: 4006377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid fluorometric analysis of unbound salicylate in whole blood.
    Baselt RC; Stewart CB
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):351-60. PubMed ID: 981790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of uremia and hemodialysis on the plasma protein binding of tolmetin.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Pharmacology; 1984; 29(6):312-9. PubMed ID: 6505005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation.
    Sweeney KR; Chapron DJ; Brandt JL; Gomolin IH; Feig PU; Kramer PA
    Clin Pharmacol Ther; 1986 Nov; 40(5):518-24. PubMed ID: 3769383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortisol binding in uremic plasma. II. Decreased cortisol binding to albumin.
    Rosman PM; Benn R; Kay M; Wallace EZ
    Nephron; 1984; 37(4):229-31. PubMed ID: 6462312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of salicylate and sulfathiazole by whole blood constituents.
    Cruze CA; Meyer MC
    J Pharm Sci; 1976 Jan; 65(1):33-7. PubMed ID: 1255431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma.
    Tavares-Almeida I; Gulyassy PF; Depner TA; Jarrard EA
    Biochem Pharmacol; 1985 Jul; 34(14):2431-8. PubMed ID: 4015686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central nervous system salicylate.
    Reed JR; Palmisano PA
    Clin Toxicol; 1975; 8(6):623-31. PubMed ID: 6188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.
    Verbeeck RK; Boel A; Buntinx A; De Schepper PJ
    Biochem Pharmacol; 1980 Feb; 29(4):571-6. PubMed ID: 7370051
    [No Abstract]   [Full Text] [Related]  

  • 52. Decreased drug binding in serum from patients with chronic hepatic disease.
    Wallace S; Brodie MJ
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):429-32. PubMed ID: 971706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of phenothiazine neuroleptics to plasma proteins.
    Verbeeck RK; Cardinal JA; Hill AG; Midha KK
    Biochem Pharmacol; 1983 Sep; 32(17):2565-70. PubMed ID: 6137223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased plasma protein binding of diazoxide in uremia.
    O'Malley K; Velasco M; Pruitt A; McNay JL
    Clin Pharmacol Ther; 1975 Jul; 18(1):53-8. PubMed ID: 1149362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of temperature on the binding of salicylate by human serum albumin.
    Zaroslinski JF; Keresztes-Nagy S; Mais RF; Oester YT
    Biochem Pharmacol; 1974 Jun; 23(12):1767-76. PubMed ID: 4841305
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of salicylate on serum protein binding and red blood cell uptake of acetazolamide in vitro.
    Sweeney KR; Chapron DJ; Kramer PA
    J Pharm Sci; 1988 Sep; 77(9):751-6. PubMed ID: 3225768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thermodynamics of the binding of salicylate to human serum albumin: evidence of non-competition with imidazole.
    Matias I; Ceballos A; Gonzalez-Velasco F; Cachaza JM
    J Pharm Pharmacol; 1989 Feb; 41(2):123-5. PubMed ID: 2568420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B; Di Giulio S; Nicolaï A; Drüeke T; Debray M; Boulu RG
    Nephrologie; 1982; 3(1):19-22. PubMed ID: 7088259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of heparin injection on plasma protein binding of 1-anilino-8-naphthalenesulfonate and salicylate in rats.
    Sato J; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacobiodyn; 1980 Dec; 3(12):720-3. PubMed ID: 7277188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cortisol binding in uremic plasma. I. Absence of abnormal cortisol binding to cortisol binding to corticosteroid-binding globulin.
    Rosman PM; Benn R; Kay M; Tito J; Wallace EZ
    Nephron; 1984; 37(3):160-5. PubMed ID: 6738767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.